Choice Hotels International Inc

This proposal asks shareholders to cast a non-binding advisory vote to approve the Company’s executive compensation as described in the proxy (the CD&A, compensation tables and narrative). Management seeks shareholder endorsement to validate its pay-for-performance design, which emphasizes a high proportion of at-risk compensation (e.g., a large share of CEO and other NEO pay in performance-based PVRSUs and short-term incentives tied to operating income, enterprise revenue and strategic initiatives). The Board and the Human Capital and Compensation Committee argue the program aligns executives with shareholder interests through long-term performance metrics (multi-year cumulative EPS with a relative TSR modifier) and robust governance features (independent committee oversight, independent compensation consultant, clawback policy, ownership guidelines, no hedging/limited pledging). The proposal is advisory and non-binding; however, the Committee will consider the vote outcome in future compensation decisions and shareholder engagement. Company context includes recent strong shareholder outreach (engaging holders representing over 90% of stock) and a 95% say-on-pay support in 2025, which management cites as evidence of broad shareholder support for the program. Key design features that bear on investor evaluation include the use of PVRSUs with a +/-15% TSR modifier, a substantial portion of pay at risk (83% for CEO in 2025), detailed short-term incentive metrics and adjustments, and potential severance/change-in-control arrangements disclosed in the proxy. Investors should weigh the alignment benefits of performance-based equity against recent TSR and payout outcomes (e.g., varying PVRSU certification results) and consider whether disclosed governance mitigants and shareholder engagement are sufficient to address concerns about payout discretion, goal-setting rigor, and severance arrangements. The Board’s recommendation and historical strong support suggest management expects affirmative investor endorsement, but the vote remains an important indicator of shareholder sentiment that could influence future plan design.

This management proposal asks shareholders to approve an amendment to the Company’s Certificate of Incorporation to increase the permissible Board size range. Management frames the change as a governance and succession-planning tool: by expanding the allowable range (from the existing three-to-twelve to five-to-fifteen), the Board can more easily add directors with needed skills or effect orderly refreshment without repeatedly amending governing documents. The Board and its Corporate Governance and Nominating Committee state the amendment will provide flexibility for transition and succession, adding expertise and addressing future needs. From a governance perspective, the change is procedurally simple but strategically significant: increasing the maximum permitted number of directors gives the incumbent Board discretion to appoint new members between annual meetings, which can accelerate refreshment but also raises questions about potential board-stacking if used opportunistically. The proxy discloses concentrated ownership (the Bainum family and affiliated groups control roughly 43% of outstanding shares), which moderates the risk of unilateral board changes but also means any expansion may be influenced by dominant shareholders’ preferences. The Board indicates the amendment is contingent on a bylaw change and was adopted unanimously by the Board; the proposal requires a majority of outstanding shares to approve, a relatively high threshold that ensures broad shareholder assent for the governance change. Investors should evaluate whether the stated objectives—adding skills, smoothing succession, and enhancing diversity/refreshment—are compelling relative to the governance trade-offs, and whether the company’s disclosure about nomination processes, independence standards, and committee oversight mitigates potential concerns. Given the Board’s current composition and stated governance practices (independent committees, lead independent director, tenure balance), approval may be a reasonable step to improve flexibility, but shareholders should monitor how and when any new seats are filled to ensure alignment with long-term shareholder interests.